메뉴 건너뛰기




Volumn 103, Issue 20, 2006, Pages 7817-7822

Epidermal growth factor receptor variant III mutations in lung tumorigenesis and sensitivity to tyrosine kinase inhibitors

(24)  Ji, Hongbin a   Zhao, Xiaojun a   Yuza, Yuki a   Shimamura, Takeshi a   Li, Danan a   Protopopov, Alexei a   Jung, Boonim L a   McNamara, Kate a   Xia, Huili a   Glatt, Karen A a   Thomas, Roman K a,d   Sasaki, Hidefumi c   Horner, James W a   Eck, Michael a   Mitchell, Albert b   Sun, Yangping b   Al Hashem, Ruqayyah b   Bronson, Roderick T d   Rabindran, Sridhar K e   Discafani, Carolyn M e   more..


Author keywords

Irreversible inhibitor; Lung cancer; Lung squamous cell carcinoma

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 3; ERLOTINIB; GEFITINIB; PROTEIN TYROSINE KINASE INHIBITOR;

EID: 33646716077     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0510284103     Document Type: Article
Times cited : (236)

References (38)
  • 25
    • 0037037818 scopus 로고    scopus 로고
    • Kaye, F. J. (2002) Oncogene 21, 6908-6914.
    • (2002) Oncogene , vol.21 , pp. 6908-6914
    • Kaye, F.J.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.